Progesterone vs Placebo Therapy for Women With Epilepsy

Completed · Phase 3 · Has a placebo group

Conditions studied: Epilepsy

In brief

The purpose of this investigation was to determine if cyclic adjunctive progesterone supplement is superior to placebo in the treatment of intractable seizures in women with and without catamenial epilepsy.

Key facts

Study ID: NCT00029536
Run by: Beth Israel Deaconess Medical Center
People needed: 294
Starts: 2000-10-01
Expected to finish: 2010-06-01
Last updated by the study team: 2017-06-05

Who can join

Age: 13 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

Where it is running

University of Southern California, Keck School of Medicine — Los Angeles, California, United States
Emory University School of Medicine — Atlanta, Georgia, United States
University of Maryland — Baltimore, Maryland, United States
Johns Hopkins Bayview Medical Center; Johns Hopkins Hospital — Baltimore, Maryland, United States
Brigham and Women's Hospital — Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Harvard Neuroendocrine Unit — Boston, Massachusetts, United States
Henry Ford Hospital — Detroit, Michigan, United States
MINCEP Epilepsy Care — Minneapolis, Minnesota, United States
Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
New York Presbyterian Hospital- Weill Medical College of Cornell University, Comprehensive Epilepsy Center — New York, New York, United States
Columbia Medical Center — New York, New York, United States
Ohio State University — Columbus, Ohio, United States
Thomas Jefferson University Hospital, Comprehensive Epilepsy Center — Philadelphia, Pennsylvania, United States
University of Virginia — Charlottesville, Virginia, United States
Montreal Neurological Institute — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.